CERS today
$1.94-$0.18 (-8.49%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $3.47
Key levels
Resistance$2.33
Resistance$2.11
Support$1.85
Support$1.68
Latest news & SEC filings
EarningsCerus Posts Q3 2026 Results
EarningsCerus Discusses Third-Quarter 2026 Results on Conference Call
SEC FilingCerus Corp filed a shelf registration for future offerings (Form S-3)
DealCerus files prospectus for up to $150M securities offering
All CERS news →About Cerus
Cerus makes a pathogen-reduction technology for donated blood, sold under the INTERCEPT brand. The platform is used to treat platelet and plasma components, and a version for treating whole blood-derived red cells is under development. Its customers are blood collection centers and hospitals, mainly across North America and Europe.
Based on the company's 10-K filed Mar 2, 2026.
Nasdaq · Healthcare
CERUS CORP (CERS)
What Is the Price Target for CERS?
SEPT Low Target
$4.00
SEPT Mid Target
$4.00
SEPT High Target
$4.00
Analyst Consensus
$4.00
Is CERS a Buy or Sell Right Now?
Thesis
- •Revenue growing 16.1% YoY with ACCELERATING trend — accelerating momentum.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CERS.
Start Free Trial →Is CERS Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$3.24
19
Moat Score
NONE
5/9
Piotroski Score
-3.8
Altman Z-Score
What Is Smart Money Doing with CERS?
Insider Signal
SELLING
0 buys / 12 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| BJERKHOLT ERIC | director | Sale | 20,454 | $53K | Jun 9, 2026 |
| Lucena Ann | director | Buy | 60,000 | - | Jun 2, 2026 |
| BJERKHOLT ERIC | director | Buy | 60,000 | - | Jun 2, 2026 |
| NACHTSHEIM JAMI K | director | Buy | 60,000 | - | Jun 2, 2026 |
| Witney Frank | director | Buy | 60,000 | - | Jun 2, 2026 |
| Gregory Dean A. | director | Buy | 60,000 | - | Jun 2, 2026 |
| Shan Hua | director | Buy | 60,000 | - | Jun 2, 2026 |
| Jayaraman Vivek K | officer | Sale | 16,667 | $50K | May 29, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CERS Growth Story
Revenue YoY
16.1%
3yr Revenue CAGR
7.5%
EPS Growth YoY
27.27%
FCF Growth YoY
-87.0%
Revenue Trend
ACCELERATING
Dark Pool Trades for CERS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CERS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:01:27 | $1.94 | 7,297 | $$14K | SELL |
| 21:00:08 | $1.94 | 8,936 | $$17K | SELL |
| 21:00:00 | $1.94 | 2,300 | $$4K | BUY |
| 21:00:00 | $1.94 | 1,000 | $$2K | BUY |
| 20:59:54 | $1.93 | 1,600 | $$3K | SELL |
5 dark pool trades shown · $$41K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CERUS CORP (CERS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CERS — frequently asked questions
What is CERS stock price today?
CERUS CORP (CERS) is at $1.94, down 8.49% (-$0.18) at the Nov 12, 2026 close.
Why is CERS stock moving today?
Latest CERS news — Nov 3, 2026: Cerus Posts Q3 2026 Results · Nov 2, 2026: Cerus Discusses Third-Quarter 2026 Results on Conference Call
What is the CERS price target?
The average analyst price target for CERS is $4.00, ranging from $4 to $4, based on 1 analysts. Latest: BTIG upgrade on May 1, 2026.
What do analysts rate CERS?
Analyst ratings for CERS: 1 Buy, 0 Hold, 0 Sell — consensus Buy.
Did CERS beat earnings?
CERS last reported on Nov 2, 2026: EPS -$0.00 vs -$0.01 expected — a beat of 78.4%.
Does CERS pay a dividend?
CERS does not currently pay a dividend.
What are CERS support and resistance levels?
Support: $1.85, $1.68, $1.47. Resistance: $2.11, $2.33, $2.52.
What are insiders doing with CERS?
Insider activity: SELLING, 0 buys and 12 sells in the last 90 days.
What is the latest news on CERS?
Nov 3, 2026: Cerus Posts Q3 2026 Results · Nov 2, 2026: Cerus Discusses Third-Quarter 2026 Results on Conference Call · Nov 2, 2026: Cerus Corp filed a shelf registration for future offerings (Form S-3)